this isn't dilution to get to production. This is dilution for...

First 26 Last

Share
Profile

Follow
falcon347

2,435 Posts.

349

24/09/14

11:24

Post #: 14019992
Share

Originally posted by Neilst ↑

If this is a bad deal for gun then why has the board and management given it a thumbs up when they all have a vested interest in seeing gun perform and move forward. This company has been in the doldrums for years and with most share holders reluctant to contribute more funds to a company that is cash strapped and needs major capital inflow to survive and progress its assets this seems a logical means of achieving it. If our only argument against is dilution then show me a junior explorer that has not undergone dilution to get to production and I will bare my posterior in bourke street. The only asset gun has which is ready for development is Coburn, and with mineral sand products value being so low we are unable to find funding for its development. It is time for gun to role the dice and for it to survive this deal is crucial. As share holders in highly speculative companies such as gun we should always consider our investment as a high risk gamble.

Cheers ns

DYOR

Expand

this isn't dilution to get to production. This is dilution for exploration of a greenfields project. I would prefer if gunson did a small raising, waited for the feasability study of mt gunson then attempted a raising and dilution to get to PRODUCTION. With a favorable feasability study the SP would be significantly higher and less dilution. Each to their own

GUN Price at posting: 1.9¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 42 more messages in this thread...

First 26 Last

Add GUN (ASX) to my watchlist

this isn't dilution to get to production. This is dilution for...

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News